Life's Essential 8 and 10-Year and Lifetime Risk of Atherosclerotic Cardiovascular Disease in China.

[1]  S. Redline,et al.  Redefining Cardiovascular Health to Include Sleep: Prospective Associations With Cardiovascular Disease in the MESA Sleep Study , 2022, Journal of the American Heart Association.

[2]  D. Labarthe,et al.  Status of Cardiovascular Health in US Adults and Children Using the American Heart Association’s New “Life’s Essential 8” Metrics: Prevalence Estimates From the National Health and Nutrition Examination Survey (NHANES), 2013 Through 2018 , 2022, Circulation.

[3]  W. Rosamond,et al.  Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association , 2022, Circulation.

[4]  Shuohua Chen,et al.  Effectiveness of a Workplace-Based, Multicomponent Hypertension Management Program in Real-World Practice: A Propensity-Matched Analysis , 2021, Hypertension.

[5]  Shuohua Chen,et al.  Ideal Cardiovascular Health Metric and Its Change With Lifetime Risk of Cardiovascular Diseases: A Prospective Cohort Study , 2021, Journal of the American Heart Association.

[6]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[7]  R. Vasan,et al.  Association of Changes in Cardiovascular Health Metrics and Risk of Subsequent Cardiovascular Disease and Mortality , 2020, Journal of the American Heart Association.

[8]  P. Whincup,et al.  Cardiovascular Health and Stroke in Older British Men , 2020, Stroke.

[9]  R. Peto,et al.  Quality of primary health care in China: challenges and recommendations , 2020, The Lancet.

[10]  Control Branch.  [Chinese guideline on healthy lifestyle to prevent cardiometabolic diseases]. , 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[11]  C. Murray,et al.  Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.

[12]  Ming Liu,et al.  Stroke in China: advances and challenges in epidemiology, prevention, and management , 2019, The Lancet Neurology.

[13]  Yichong Li,et al.  Burden of Cardiovascular Diseases in China, 1990-2016: Findings From the 2016 Global Burden of Disease Study , 2019, JAMA cardiology.

[14]  [Guideline on the assessment and management of cardiovascular risk in China]. , 2019, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[15]  A. Singh‐Manoux,et al.  Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events , 2018, JAMA.

[16]  Dong Zhao,et al.  Epidemiology of cardiovascular disease in China: current features and implications , 2018, Nature Reviews Cardiology.

[17]  Danielle M. Enserro,et al.  Twenty‐Year Trends in the American Heart Association Cardiovascular Health Score and Impact on Subclinical and Clinical Cardiovascular Disease: The Framingham Offspring Study , 2018, Journal of the American Heart Association.

[18]  Xueli Yang,et al.  Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project , 2018, Science China Life Sciences.

[19]  K. Rexrode,et al.  Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk , 2018, Stroke.

[20]  F. Hu,et al.  Longitudinal Change in Fasting Blood Glucose and Myocardial Infarction Risk in a Population Without Diabetes , 2017, Diabetes Care.

[21]  Xiaodong Tan,et al.  Healthy China 2030: A Vision for Health Care. , 2017, Value in health regional issues.

[22]  Lawrence J. Fine,et al.  Decline in Cardiovascular Mortality: Possible Causes and Implications , 2017, Circulation research.

[23]  Xueli Yang,et al.  Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.

[24]  Alan D. Lopez,et al.  Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.

[25]  Danielle M. Enserro,et al.  Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study , 2016, Circulation. Heart failure.

[26]  S. Lai,et al.  Status of cardiovascular health in Chinese adults. , 2015, Journal of the American College of Cardiology.

[27]  Young-Jin Ko,et al.  Cardiovascular Health Metrics and All-cause and Cardiovascular Disease Mortality Among Middle-aged Men in Korea: The Seoul Male Cohort Study , 2013, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[28]  Xiang Gao,et al.  Ideal Cardiovascular Health Metrics and the Risks of Ischemic and Intracerebral Hemorrhagic Stroke , 2013, Stroke.

[29]  Alan D. Lopez,et al.  Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[30]  Kuibao Li,et al.  Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City , 2012, Circulation. Cardiovascular quality and outcomes.

[31]  R. Sacco,et al.  Ideal Cardiovascular Health Predicts Lower Risks of Myocardial Infarction, Stroke, and Vascular Death Across Whites, Blacks, and Hispanics: The Northern Manhattan Study , 2012, Circulation.

[32]  Mark D. Huffman,et al.  Cardiovascular Health Behavior and Health Factor Changes (1988–2008) and Projections to 2020: Results From the National Health and Nutrition Examination Surveys , 2012, Circulation.

[33]  Avis J. Thomas,et al.  Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[34]  Martha L. Daviglus,et al.  Status of Cardiovascular Health in US Adults: Prevalence Estimates From the National Health and Nutrition Examination Surveys (NHANES) 2003–2008 , 2012, Circulation.

[35]  Martin O'Flaherty,et al.  Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. , 2010, JAMA.

[36]  Dong Zhao,et al.  Future Cardiovascular Disease in China: Markov Model and Risk Factor Scenario Projections From the Coronary Heart Disease Policy Model–China , 2010, Circulation. Cardiovascular quality and outcomes.

[37]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[38]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[39]  D. Spiegelman,et al.  Point and interval estimates of partial population attributable risks in cohort studies: examples and software , 2007, Cancer Causes & Control.

[40]  J. Satagopan,et al.  A note on competing risks in survival data analysis , 2004, British Journal of Cancer.

[41]  P. Whelton,et al.  International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. , 2004, Ethnicity & disease.

[42]  Wu Yangfen.  Current status of major cardiovascular risk factors in Chinese populations and their trends in the past two decades , 2001 .

[43]  R B D'Agostino,et al.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. , 2000, Statistics in medicine.

[44]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .